CalciMedica (CALC) vs MetaVia (MTVA)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
MetaVia is the larger company by market cap ($9.2 million vs $9.1 million), about 1.0 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Head-to-head
| Metric | CALC | MTVA |
|---|---|---|
| Share price | $1.33 | $1.39 |
| Market cap | $9.08M | $9.16M |
| 1-day change | -10.14% | -4.80% |
| YTD return | -95.51% | — |
| 1-year return | -91.27% | — |
| EPS (TTM) | $-6.85 | $-3.65 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $36.00 | $14.85 |
| 52-week low | $1.33 | $0.966 |
| Distance from 52-week high | -96.31% | -90.64% |
| Average volume | 73.03K | 230.88K |
| Shares outstanding | 6.83M | 6.59M |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
CALC vs MTVA FAQ
Which is bigger, CalciMedica or MetaVia?
MetaVia (MTVA) is larger, with a market capitalization of $9.16M compared with $9.08M for CalciMedica (CALC).
Are CalciMedica and MetaVia in the same industry?
Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.